These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35196838)

  • 1. Treatment of Nanophthalmos-Related Uveal Effusion with Two- vs. Four-Quadrant Partial-Thickness Sclerectomy and Sclerotomy Surgery.
    Özdek Ş; Yalınbaş Yeter D; Özmen MC; Hasanreisoğlu M
    Turk J Ophthalmol; 2022 Feb; 52(1):37-44. PubMed ID: 35196838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-thickness sclerotomy for uveal effusion syndrome.
    Kong M; Kim JH; Kim SJ; Kang SW
    Korean J Ophthalmol; 2013 Aug; 27(4):294-8. PubMed ID: 23908578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
    Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
    Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of serous retinal detachment following partial sclerectomy with mitomycin C in nanophthalmos.
    Venkatesh P; Majumdar SS; Kakkar A; Singh S; Gogia V; Garg S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):287-9. PubMed ID: 23676234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerotomy in uveal effusion syndrome.
    Faulborn J; Kölli H
    Retina; 1999; 19(6):504-7. PubMed ID: 10606449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanophthalmos with longstanding choroidal effusion and serous retinal detachment.
    Han L; Cairns JD
    Aust N Z J Ophthalmol; 1997 May; 25(2):181-3. PubMed ID: 9267610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser and unsutured sclerotomy in nanophthalmos.
    Jin JC; Anderson DR
    Am J Ophthalmol; 1990 May; 109(5):575-80. PubMed ID: 2333921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of uveal effusion syndrome.
    Lee JH; Choi JY; Kim SS
    Korean J Ophthalmol; 2006 Jun; 20(2):124-7. PubMed ID: 16892650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology.
    Uyama M; Takahashi K; Kozaki J; Tagami N; Takada Y; Ohkuma H; Matsunaga H; Kimoto T; Nishimura T
    Ophthalmology; 2000 Mar; 107(3):441-9. PubMed ID: 10711879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscope-Assisted ab externo Surgery for the Treatment of Primary Rhegmatogenous Retinal Detachment - New Tech Meets Old Art.
    Frisina R; Forlini M; Date P; Meduri A; Pinackatt JS; Sborgia L; Besozzi G; Parolini B
    Ophthalmic Res; 2020; 63(1):34-40. PubMed ID: 31352453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exudative retinal detachment in nanophthalmos.
    Krohn J; Seland JH
    Acta Ophthalmol Scand; 1998 Aug; 76(4):499-502. PubMed ID: 9716342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Results of Vitrectomy and Sclerectomy in a Patient with Nanophthalmic Uveal Effusion Syndrome.
    Popov I; Popova V; Krasnik V
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33572746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report.
    Kaewsangthong K; Thoongsuwan S; Uiprasertkul M; Phasukkijwatana N
    BMC Ophthalmol; 2020 Jul; 20(1):311. PubMed ID: 32727414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial thickness sclerectomy to treat exudative retinal detachment secondary a submacular choroidal hemangioma in a Sturge-Weber syndrome.
    Parolini B; Cardillo D; Baldi A; Di Salvatore A; Finzi A; Pinackatt SJ; Frisina R; Besozzi G
    Int Ophthalmol; 2019 Feb; 39(2):491-495. PubMed ID: 30564966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial thickness sclerectomy and intravitreal anti-VEGF therapy for intractable uveal effusion syndrome.
    Guo J; Cao X; Li X
    Int Ophthalmol; 2019 Aug; 39(8):1885-1890. PubMed ID: 30043134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrantic vortex vein decompression with subretinal fluid drainage for manangement of Nanophthalmic choroidal effusions- a review of literature and case series.
    Khatri A; Singh S; Joshi K; Kharel M
    BMC Ophthalmol; 2019 Oct; 19(1):210. PubMed ID: 31651283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual rapid resolution of postsclerectomy exudative retinal detachment with topical NSAIDs therapy in a case of nanophthalmos.
    Tong B; Wang C; Qi X
    J Int Med Res; 2020 Aug; 48(8):300060519847376. PubMed ID: 31081412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.
    Zhou N; Yang L; Xu X; Wei W
    Front Med (Lausanne); 2022; 9():785444. PubMed ID: 35755052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and treatment outcomes of an algorithmic approach to uveal effusion syndrome.
    Desai A; Parameswarappa DC; Senthil S; Jayanna S; Pappuru RR; Jalali S; Rani PK
    Indian J Ophthalmol; 2022 Dec; 70(12):4349-4356. PubMed ID: 36453343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vortex vein decompression for nanophthalmic uveal effusion.
    Brockhurst RJ
    Arch Ophthalmol; 1980 Nov; 98(11):1987-90. PubMed ID: 7436831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.